Skip to main content
. 2021 Aug 25;44(5):1183–1195. doi: 10.1007/s13402-021-00630-z

Table 1.

Immunohistochemical detection of YKL-40 protein expression in a multi-tumor tissue microarray Staining intensity was assessed on a scale from ‘0’ = negative over ‘1’ = weak to ‘4’ = high expression

YKL-40 Staining Intensity % Matrix Cells %
Organ system Tissue Specific tumor entity n 0 1 2 3 4 Pos  > Tumor
Skin Basalioma 41 4.9 36.6 46.3 12.2 0.0 76.2 48.8
Benign Naevus 26 0.0 11.5 26.9 42.3 19.2 81.5 7.7
Squamous cell carcinoma 43 7.0 14.0 39.5 23.3 16.3 55.6 14.0
Melanoma 42 7.1 16.7 21.4 35.7 19.0 78.0 26.8
Head, Chest, and Respiratory Tract Larynx Squamous cell carcinoma 41 22.0 19.5 31.7 24.4 2.4 34.9 24.4
Oral cavity Squamous cell carcinoma 50 2.0 10.0 32.0 48.0 8.0 71.4 10.2
Lung Squamous cell carcinoma 33 9.1 15.2 24.2 45.5 6.1 56.3 16.7
Bronchial carcinoma, large cell 22 9.1 18.2 31.8 18.2 22.7 72.7 28.6
Adenocarcinoma 32 0.0 9.4 31.3 40.6 18.8 90.6 22.6
Bronchoalveolar carcinoma 6 0.0 33.3 50.0 16.7 0.0 16.7 0.0
Small-cell carcinoma 19 0.0 5.3 52.6 26.3 15.8 50.0 100.0
Salivary glands Parotis, pleomorphic adenoma 48 58.3 20.8 18.8 2.1 0.0 2.1 60.4
Parotis, Warthin tumor 44 2.3 22.7 25.0 43.2 6.8 0.0 2.3
Basal cell adenoma 14 7.1 28.6 35.7 28.6 0.0 21.4 7.1
Gynecologic Vagina Squamous cell carcinoma 24 29.2 20.8 25.0 16.7 8.3 45.8 37.5
Vulva Squamous cell carcinoma 33 0.0 6.1 30.3 39.4 24.2 60.0 12.1
Cervix Squamous cell carcinoma 37 27.0 27.0 18.9 16.2 10.8 35.1 37.8
Adenocarcinoma 44 2.3 11.4 40.9 34.1 11.4 55.6 6.8
Endometrium Carcinoma, endometroid 47 55.3 27.7 17.0 0.0 0.0 4.3 59.6
Carcinoma, serous 36 19.4 27.8 36.1 13.9 2.8 13.9 22.2
Uterus Stroma sarcoma 12 8.3 8.3 50.0 33.3 0.0 50.0 16.7
Carcinosarcoma 46 4.3 32.6 39.1 21.7 2.2 45.7 13.0
Ovaries Carcinoma, endometroid 25 4.0 28.0 20.0 32.0 16.0 67.9 16.0
Carcinoma, serous 39 5.1 15.4 46.2 23.1 10.3 76.2 26.3
Carcinoma, mucinous 23 43.5 17.4 26.1 8.7 4.3 50.0 56.5
Brenner tumor 5 80.0 0.0 20.0 0.0 0.0 66.7 80.0
Breast Carcinoma, ductal (NST) 30 56.7 20.0 13.3 10.0 0.0 10.0 56.7
Carcinoma, lobular 28 7.1 25.0 46.4 21.4 0.0 63.3 25.9
Carcinoma, medullary 11 0.0 0.0 63.6 36.4 0.0 45.5 0.0
Carcinoma, tubular 10 0.0 20.0 20.0 40.0 20.0 83.3 20.0
Carcinoma, mucinous 14 7.1 21.4 14.3 28.6 28.6 35.7 21.4
Carcinoma, phyllodes 44 18.2 43.2 27.3 11.4 0.0 47.8 50.0
Gastrointestinal Large intestine Adenoma, low grade 17 29.4 23.5 29.4 11.8 5.9 17.6 29.4
Adenoma, high grade 19 21.1 21.1 26.3 21.1 10.5 55.0 31.6
Adenocarcinoma 32 3.1 15.6 34.4 43.8 3.1 56.3 12.5
Small intestine Adenocarcinoma 6 0.0 0.0 83.3 16.7 0.0 71.4 33.3
Stomach Carcinoma, diffuse type 29 65.5 27.6 6.9 0.0 0.0 37.5 86.2
Carcinoma, intestinal type 30 3.3 16.7 46.7 26.7 6.7 74.2 20.7
Esophagus Adenocarcinoma 31 29.0 32.3 22.6 12.9 3.2 34.4 35.5
Squamous cell carcinoma 26 7.7 15.4 30.8 26.9 19.2 59.3 23.1
Anal canal Squamous cell carcinoma 18 27.8 11.1 33.3 27.8 0.0 42.1 27.8
Liver Cholangiocellular carcinoma 27 11.1 22.2 18.5 18.5 29.6 71.4 22.2
Hepatocellular carcinoma 39 2.6 7.7 38.5 41.0 10.3 39.4 6.1
Pancreas Adenocarcinoma, ductal 36 36.1 33.3 25.0 5.6 0.0 25.6 50.0
Adenocarcinoma, papillary 18 33.3 50.0 11.1 5.6 0.0 16.7 44.4
Neuroendocrine Tumor 27 7.4 18.5 40.7 18.5 14.8 57.1 14.8
Gastrointestinal Stroma tumor 33 6.1 12.1 42.4 36.4 3.0 73.0 25.0
Urogenital Urothelial Carcinoma, pTa 35 0.0 8.6 20.0 42.9 28.6 80.6 3.4
Carcinoma, pT2-4 43 0.0 9.3 25.6 44.2 20.9 97.6 23.8
Kidney Carcinoma, clear cell 44 4.5 18.2 43.2 31.8 2.3 54.5 11.6
Carcinoma, papillary 34 0.0 38.2 29.4 29.4 2.9 47.2 12.1
Carcinoma, chromophobe 43 18.6 16.3 23.3 32.6 9.3 16.3 20.9
Oncocytoma 41 2.4 0.0 9.8 19.5 68.3 56.1 2.4
Prostate Adenocarcinoma 46 32.6 17.4 30.4 10.9 8.7 60.9 52.2
Germ cell tumor Seminoma 48 2.1 16.7 68.8 12.5 0.0 68.1 23.4
Carcinoma, embryonal 43 4.7 18.6 58.1 18.6 0.0 55.3 26.3
Yolk sac tumor 41 4.9 19.5 41.5 22.0 12.2 57.9 18.9
Teratoma 29 3.4 10.3 41.4 27.6 17.2 77.4 39.3
Endocrine Thyroid Adenoma 42 11.9 40.5 31.0 11.9 4.8 45.2 23.8
Papillary carcinoma 45 37.8 20.0 22.2 17.8 2.2 28.3 37.8
Follicular carcinoma 45 4.4 26.7 42.2 17.8 8.9 47.8 11.1
Medullary carcinoma 45 40.0 17.8 35.6 6.7 0.0 28.3 46.7
Anaplastic carcinoma 24 8.3 20.8 33.3 25.0 12.5 37.5 20.8
Adrenal gland Adenoma 43 2.3 9.3 62.8 25.6 0.0 7.0 4.7
Carcinoma 13 7.7 23.1 30.8 23.1 15.4 15.4 8.3
Pheochromocytoma 26 19.2 23.1 42.3 15.4 0.0 20.0 20.8
Neuroendocrine tumor 22 18.2 18.2 54.5 4.5 4.5 45.8 36.4
Hematologic Hodgkin-Lymphoma 37 62.2 24.3 10.8 2.7 0.0 45.9 75.7
Non-Hodgkin-Lymphoma 42 54.8 26.2 14.3 4.8 0.0 47.6 57.1
Thymoma 26 7.7 53.8 34.6 3.8 0.0 30.8 30.8
Soft tissue Leiomyoma 48 8,3 29.2 45.8 14.6 2.1 0.0 8.3
Leiomyosarcoma 48 8,3 10.4 56.3 22.9 2.1 35.4 12.5